Moszyńska, Adrianna

Primary endothelial cell–specific regulation of hypoxia‐inducible factor (HIF)‐1 and HIF‐2 and their target gene expression profiles during hypoxia

Bartoszewski, R., Moszyńska, A., Serocki, M., Cabaj, A., Polten, A., Ochocka, R., Dell'Italia, L., Bartoszewska, S., Króliczewski, J., Dąbrowski, M., et al. (2019) · The FASEB Journal

Cancer, Hypoxia, and MetabolismAngiogenesis and VEGF in Cancer

Cited by 199

The transition from HIF-1 to HIF-2 during prolonged hypoxia results from reactivation of PHDs and HIF1A mRNA instability

Jaśkiewicz, M., Moszyńska, A., Króliczewski, J., Cabaj, A., Bartoszewska, S., Charzyńska, A., Gebert, M., Dąbrowski, M., Collawn, J. F., & Bartoszewski, R. (2022) · Cellular & Molecular Biology Letters

Cancer, Hypoxia, and MetabolismErythropoietin and Anemia Treatment

Cited by 143

The hypoxia‐induced changes in miRNA‐mRNA in RNA ‐induced silencing complexes and HIF ‐2 induced miRNAs in human endothelial cells

Moszyńska, A., Jaśkiewicz, M., Serocki, M., Cabaj, A., Crossman, D. K., Bartoszewska, S., Gebert, M., Dąbrowski, M., Collawn, J. F., & Bartoszewski, R. (2022) · The FASEB Journal

MicroRNA in disease regulationCancer, Hypoxia, and Metabolism

Cited by 53

Functional and HRE motifs count analysis of induction of selected hypoxia-responsive genes by HIF-1 and HIF-2 in human umbilical endothelial cells

Cabaj, A., Moszyńska, A., Charzyńska, A., Bartoszewski, R., & Dąbrowski, M. (2022) · Cellular Signalling

Cancer, Hypoxia, and MetabolismGenomics and Chromatin Dynamics

Cited by 37

Hypoxia-inducible factor (HIF)-3α2 serves as an endothelial cell fate executor during chronic hypoxia

Jaśkiewicz, M., Moszyńska, A., Serocki, M., Króliczewski, J., Bartoszewska, S., Collawn, J. F., & Bartoszewski, R. (2022) · IfADo - Leibniz Research Centre for Working Environment and Human Factors, Dortmund

Cancer, Hypoxia, and MetabolismAngiogenesis and VEGF in Cancer

Cited by 37

Challenges in mimicking hypoxia: insights into HIF-regulated MiRNA expression induced by DMOG and CoCl2

Barton, A., Jaśkiewicz, M., Więch -Walów, A., Moszyńska, A., Cabaj, A., Wielockx, B., Schaefer, L., Collawn, J. F., & Bartoszewski, R. (2025) · Cell Communication and Signaling

Cancer, Hypoxia, and MetabolismAngiogenesis and VEGF in Cancer

Cited by 14

Combined anticancer therapy with imidazoacridinone analogue C‐1305 and paclitaxel in human lung and colon cancer xenografts—Modulation of tumour angiogenesis

Świtalska, M., Filip‐Psurska, B., Milczarek, M., Psurski, M., Moszyńska, A., Dąbrowska, A. M., Gawrońska, M., Krzymiński, K., Bagiński, M., Bartoszewski, R., et al. (2022) · Journal of Cellular and Molecular Medicine

Angiogenesis and VEGF in CancerHeterocyclic Compound Synthesis and Bioactivity

Cited by 13

EPAS1 resistance to miRNA-based regulation contributes to prolonged expression of HIF-2 during hypoxia in human endothelial cells

Jaśkiewicz, M., Moszyńska, A., Gebert, M., Collawn, J. F., & Bartoszewski, R. (2023) · Gene

Cancer, Hypoxia, and MetabolismMicroRNA in disease regulation

Cited by 9